Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Change in the Number of Shares and Votes in Immunicum | |||
| By: Nasdaq / GlobeNewswire - 31 Jan 2018 | Back to overview list |
||
Press Release 31 January 2018 Change in the Number of Shares and Votes in Immunicum Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors ("Immunicum" or the "Company"), today announced that the number of shares and votes in Immunicum as per 31 January 2018 amounts to 50,958,531. The number of shares and votes in Immunicum has, as a result of a rights issue of shares, increased with 24,999,990, from 25,958,541 to 50,958,531. As per 31 January 2018, there is thus 50,958,531 registered shares and votes in the Company and the share capital amounts to SEK 2,547,926.55. The quotient value per share is accordingly unchanged at SEK 0.05. Immunicum does not hold any own shares. The information is such information that Immunicum is obliged to make public pursuant to Financial Instruments Trading Act. The information was released for public disclosure through the contact persons detailed below on 31 January 2018 at 8.00 am CET. For more information, please contact: Carlos de Sousa, CEO, Immunicum Investor Relations Sweden Helena Stångberg Investor and Media Relations EU/US Gretchen Schweitzer and Joanne Tudorica
http://www.globenewswire.com/NewsRoom/AttachmentNg/4339bd3b-ec79-46bc-a1b6-b6802859452a |
|||
|
|||
 | Back to overview list | ||